In terms of revenue, Medicover Romania ranks third within the group, after Germany and Poland, with a share of 12.7%.
“The excellent results registered by the group make us confident we are on the right path in Romania too. The opening in 2017, in capital Bucharest, of the first digital histopathology department in south-eastern Europe and the increase in the number of blood collection centers, reaching a regional coverage of 75%, are among the factors boosting the company’s local business and reconfirming its position of innovation leader”, said Synevo Romania general manager Laurentiu Luca.
The company, present in Romania through Medicover centers and Synevo laboratories, reported 16.7% higher global revenue on the year in 2017, up to EUR580.2 million.
Swedish-held Medicover, listed on the Stockholm Stock Exchange, presented its intermediary financial report for 2017.